Evidence map›Paper›PMID 35989992›Full record

ArticleFrontiers in pediatrics2022

Comparative study of different surgical approaches for treatment of UPJ obstruction according to the degree/severity of hydronephrosis factor.

Peng Zhao, Cao Wang, Kaiyi Mao, Zhen Luo, Yingbo Li, Guangxu Zhou, Hongyang Tan, Hong Liu, Yucheng Mao, Hong Ma and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in pediatrics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Peng ZhaoGuizhou Children's Hospital, Zunyi, China.
Cao WangGuizhou Children's Hospital, Zunyi, China.
Kaiyi MaoGuizhou Children's Hospital, Zunyi, China.
Zhen LuoGuizhou Children's Hospital, Zunyi, China.
Yingbo LiGuizhou Children's Hospital, Zunyi, China.
Guangxu ZhouGuizhou Children's Hospital, Zunyi, China.
Hongyang TanGuizhou Children's Hospital, Zunyi, China.
Hong LiuGuizhou Children's Hospital, Zunyi, China.
Yucheng MaoGuizhou Children's Hospital, Zunyi, China.
Hong MaGuizhou Children's Hospital, Zunyi, China.
Xianhui ShangGuizhou Children's Hospital, Zunyi, China.
Bin LiuGuizhou Children's Hospital, Zunyi, China.
Zunyi Medical University · CNFirst People’s Hospital of Zunyi · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To compare the efficacy of two different surgical approaches during and after pyeloplasty according to the degree/severity of hydronephrosis factor. Materials and methods: Sixty child patients with UPJ obstruction admitted to our hospital from August 2019 to October 2021 were collected. Patients who underwent retroperitoneal laparoscopic pyeloplasty (RPLP) were enrolled into Group A ( Results: All 60 child patients were operated upon successfully without conversion to open surgery. There were no statistically significant differences in gender, age, laterality of UPJ obstruction, and body weight between the two groups, while the operation time of TLP was shorter than that of RPLP, indicating a statistically significant difference ( Conclusion: Both RPLP and TLP are safe and feasible in the treatment of UPJ obstruction, and their overall surgical effects are equivalent. For child patients with anteroposterior diameter ≤ 20 mm, RPLP is available, while patients with anteroposterior diameter >20 mm, TLP is recommended.

Indexed as

childrenpyeloplastyretroperitoneal laparoscopetransperitoneal laparoscopeUPJO

Identifiers

PMID35989992
PMCPMC9386036
OpenAlexW4289730833

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.